Instances of Use of US Forces Abroad, More from CRS
U.S. military forces have been deployed in military conflicts abroad hundreds of times over the past two centuries — not including covert actions or training exercises. An updated tabulation is given in “Instances of Use of United States Armed Forces Abroad, 1798-2010” (pdf), Congressional Research Service, March 10, 2011.
Some other noteworthy new CRS reports include the following (all pdf).
“Middle East and North Africa Unrest: Implications for Oil and Natural Gas Markets,” March 10, 2011.
“The Strategic Petroleum Reserve and Refined Product Reserves: Authorization and Drawdown Policy,” March 11, 2011.
“Terrorist Use of the Internet: Information Operations in Cyberspace,” March 8, 2011.
“International Criminal Court and the Rome Statute: 2010 Review Conference,” March 10, 2011.
“International Criminal Court Cases in Africa: Status and Policy Issues,” March 7, 2011.
“Closing Yucca Mountain: Litigation Associated with Attempts to Abandon the Planned Nuclear Waste Repository,” March 4, 2011.
“U.S. Tsunami Programs: A Brief Overview,” March 14, 2011.
Mary B. Mazanec has been appointed acting director of the Congressional Research Service. Ms. Mazanec is the current CRS deputy director. She will serve in an acting capacity until the selection of a new director is made by Librarian of Congress James H. Billington. The current director, Daniel P. Mulhollan, will retire on April 2.
Public interest groups hope that the change in CRS leadership will coincide with, or will help to promote, a change in CRS publication policy. Currently, at congressional direction, CRS does not permit direct public access to its reports.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.
Inconsistent metrics and opaque reporting make future AI power‑demand estimates extremely uncertain, leaving grid planners in the dark and climate targets on the line